Ortega A, Moreno R, Alonso-Farto J C, Almoguera I, Domínguez P, Bittini A, Martínez L, Moreno M, Sosa V, García-Fernández M A, Pérez Vázquez J M
Servicio de Medicina Nuclear. Hospital Gregorio Marañón. Madrid.
Rev Esp Med Nucl. 2001 Feb;20(1):4-10.
Administration of dipyridamole produces angina and ST depression in 20%-30% and 6%-34% of patients, respectively. This study aimed to evaluate the clinical implications of the presentation of angina and/or ST depression during the administration of dipyridamole in the study of coronary heart disease by myocardial perfusion SPECT (MPS).
The study population is constituted by 593 consecutive patients without left branch block or ventricular pacemaker rhythm who were referred to our service to undergo MPS with dipyridamole. A SPECT was performed after the administration of 99mTc-tetrosfosmine and drug stimulation with dipyridamole (0.142 mg/kg/min for 4 minutes). A coronariography was performed in 338 patients (57%). The frequency of clinical and electrical positivity and their relationship with the MPS and the coronariography were studied.
The rate of angina and ST depression was 32% (n = 190) and 10% (n = 58), respectively. Myocardial perfusion defects were observed in 465 patients (78%), and signs of scintigraphic ischemia in 311 (52%). The patients with ST depression presented a higher frequency of perfusion defects (93% vs 76%, p = 0.0012) and scintigraphic ischemia (89% vs 49%, p < 0.0001). In addition, perfusion defects in more than one territory were observed in these patients in a higher percentage (53% vs 34%, p = 0.0036). Among the patients who underwent cardiac catheterization, those who had a ST depression had a greater extension of coronary heart disease (1.8 +/- 1.2 vs 1.3 +/- 1.0 diseased vessels, respectively. p = 0.0100) and a higher frequency of multivessel disease (61% vs 43%, p = 0.0380). Those patients who had clinical positivity showed a scintigraphic ischemia more frequently (66% vs 47%, p < 0.0001), however no statistically significant differences were observed between the presence of patients with perfusion defects or in the extension of these defects as well as in the number of diseased vessels in the coronariographic study.
During the administration of dipyridamole, the ST depression is associated with more frequent scintigraphic ischemia, larger extension of perfusion defects and more diseased vessels. The appearance of angina is associated with scintigraphic ischemia, but it is not necessarily associated with the extension of perfusion defects or greater number of diseased vessels.
双嘧达莫给药后,分别有20%-30%和6%-34%的患者出现心绞痛和ST段压低。本研究旨在评估在冠心病心肌灌注单光子发射计算机断层扫描(MPS)研究中,双嘧达莫给药期间出现心绞痛和/或ST段压低的临床意义。
研究对象为593例连续的患者,这些患者无左束支传导阻滞或心室起搏心律,被转诊至我院接受双嘧达莫负荷心肌灌注单光子发射计算机断层扫描。静脉注射99mTc-替曲膦并给予双嘧达莫(0.142mg/kg/min,持续4分钟)进行药物激发后,行单光子发射计算机断层扫描。338例患者(57%)接受了冠状动脉造影。研究临床和心电图阳性的发生率及其与心肌灌注单光子发射计算机断层扫描和冠状动脉造影的关系。
心绞痛和ST段压低的发生率分别为32%(n = 190)和10%(n = 58)。465例患者(78%)观察到心肌灌注缺损,311例(52%)有核素心肌灌注显像缺血表现。出现ST段压低的患者灌注缺损(93%对76%,p = 0.0012)和核素心肌灌注显像缺血(89%对49%,p < 0.0001)的发生率更高。此外,这些患者中多个心肌节段出现灌注缺损的比例更高(53%对34%,p = 0.0036)。在接受心导管检查的患者中,出现ST段压低的患者冠心病病变范围更大(分别为1.8±1.2支病变血管对1.3±1.0支病变血管,p = 0.0100),多支血管病变的发生率更高(61%对43%,p = 0.0380)。出现临床阳性的患者核素心肌灌注显像缺血更常见(66%对47%,p < 0.000但在心肌灌注缺损的存在情况、缺损范围以及冠状动脉造影病变血管数量方面,未观察到统计学显著差异。
双嘧达莫给药期间,ST段压低与更频繁的核素心肌灌注显像缺血、更大范围的灌注缺损以及更多病变血管相关。心绞痛的出现与核素心肌灌注显像缺血相关,但不一定与灌注缺损范围扩大或更多病变血管相关。